SCHEMBL3268166

SCHEMBL3268166

O=Cc1ccc(OCc2ccccc2F)c2ccccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
USP2 O75604 1/20 0.49
LMNA P02545 1/20 0.49
HCRTR1 O43613 1/20 0.46
PRMT5 O14744 1/20 0.46
WDR77 Q9BQA1 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
KDM4E B2RXH2 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
HTT P42858 1/20 0.45
MCL1 Q07820 1/20 0.44
MAPT P10636 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
PKM P14618 2/20 0.41
DHFR P00374 1/20 0.41
CLCN2 P51788 1/20 0.41
IDO1 P14902 1/20 0.41
PARP15 Q460N3 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3267969 0.86 ALDH1A1 (0.47) ALDH1A1MEN1KMT2AIDO1MAOB
SCHEMBL3267315 0.82 HPGD (0.49) ALDH1A1LMNASMN1; SMN2KDM4EMEN1
SCHEMBL7235343 0.82 ALDH1A1 (0.52) ALDH1A1USP2LMNAHCRTR1PRMT5
SCHEMBL2930822 0.81 ALDH1A1 (0.66) ALDH1A1USP2LMNASMN1; SMN2KDM4E
SCHEMBL8621031 0.81 ALDH1A1 (0.40) ALDH1A1USP2LMNAHCRTR1SMN1; SMN2
SCHEMBL3269606 0.79 SMN1; SMN2 (0.47) ALDH1A1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL4506944 0.79 ALDH1A1 (0.51) ALDH1A1LMNAPRMT5SMN1; SMN2MEN1
SCHEMBL3269301 0.78 MAPT (0.59) ALDH1A1LMNASMN1; SMN2HTTMCL1
SCHEMBL2650190 0.78 SMN1; SMN2 (0.43) ALDH1A1LMNASMN1; SMN2KMT2AHTT
SCHEMBL3271842 0.76 MAOB (0.52) ALDH1A1LMNASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1914229-B1 NOVEL CERCOSPORAMIDE DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2010-06-16 EP disclosed
US-20090036492-A1 Novel Cercosporamide Derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-02-05 US disclosed
EP-1914229-A1 NOVEL CERCOSPORAMIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036492-A1 Novel Cercosporamide Derivative GPR119, CBR3, SLC5A2 ALDH1A1 381/4885USP2 2732/4885LMNA 4110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.